Explore how EU pharmaceutical legislation reform, EMA regulatory requirements, marketing authorisation, and EU GMP expectations are reshaping pharmaceutical compliance. This article explains the legal framework, post-approval variations, manufacturing controls, inspection readiness, and the key changes companies should monitor.
